Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
TQ-B3525 tablets
DRUG
2 trials
Sponsors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Conditions
Diffuse Large B-cell Lymphoma
Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Phase 1
A Study of TQ-B3525 in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Terminated
NCT04808570
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Start: 2021-06-05
End: 2023-11-22
Updated: 2023-11-29
Phase 2
A Study of TQ-B3525 in Subjects With Relapse/Refractory Diffuse Large B-cell Lymphoma （DLBCL）
NCT04610970
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Diffuse Large B-cell Lymphoma
Start: 2021-01-20
End: 2022-06-30
Target: 93
Updated: 2021-08-18